| 摘要 |
The present invention is a product comprising a β2 agonist and a progestin, as a combined preparation for separate, simultaneous or sequential use in the treatment or prevention of muscle loss. The present invention is also a β2 agonist selected from R, R-formoterol, indacaterol or ritodrine, for use in the treatment or prevention of muscle loss.
|
